Inaedis, Inc.
Princeton, NJ
- UEI
- ZN3PYM5VY1W9
- CAGE
- 11VU0
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 114 Castleton Rd, Princeton, NJ 08540, USA
- Website
- inaedis.com
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures using room temperature… | ACC Aberdeen Proving Ground | $1,396,936 | |
| This effort is to demonstrate the feasibility and efficacy of breakthrough rapid room-temperature aerosol dehydration… | ACC Aberdeen Proving Ground | $209,565 | |
| Sbir phase II: rapid dehydration and stabilization of biopharmaceutical formulations at room temperature -the broader… | National Science Foundation | $1,498,234 | |
| Rapid dehydration and stabilization of biopharmaceutical formulations at room temperature - abstract inaedis proposes to… | National Center for Advancing Translational Sciences | $625,268 | |
| Sttr phase i: rapid dehydration and stabilization of biopharmaceutical formulations at room temperature -the broader… | National Science Foundation | $275,000 |
About Inaedis, Inc.
Inaedis, Inc., a biopharmaceutical technology company based in Princeton, New Jersey, develops thermal stabilization platform technology for heat-sensitive medical countermeasures and vaccines as a prime contractor exclusively under small business set-asides. The vendor operates across federal R&D grants and SBIR Phase I and Phase II contracts, with all five recent awards (100%) positioned as direct prime recipients or contractees rather than subcontractor work.
Inaedis's core capability centers on Rapid Room-Temperature Aerosol Dehydration (RTAD) technology — a continuous, room-temperature dehydration process that converts liquid biopharmaceutical formulations into shelf-stable bioactive powders suitable for pulmonary, nasal, and transdermal drug delivery routes. The technology eliminates cold chain infrastructure requirements for vaccines and biologics, addressing military objectives of improving vaccine stability and reducing pharmaceutical logistics complexity. Representative work includes a $1.4 million Phase II SBIR definitive contract from the Joint PEO Chemical and Biological Defense (awarded April 13, 2026, completing April 12, 2028) for thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures; a $209.6 thousand Phase I SBIR definitive contract from the U.S. Army Research, Development and Engineering Command (awarded July 29, 2025, completing January 28, 2026) demonstrating feasibility of RTAD technology for shelf-stable bioactive powder production; and a $1.25 million NSF Technology, Innovation, and Partnerships Cooperative Agreement (awarded June 1, 2025, completing May 31, 2027) for scaling the RTAD platform across multiple protein and nucleic acid-based drug molecules.
Customer concentration splits evenly between Defense (Army SBIR and procurement) and civilian research funding. The Department of the Army Acquisition Support Center's Joint PEO Chemical and Biological Defense anchors the largest single contract ($1.4 million), while the National Science Foundation placed two R&D grants totaling $1.525 million. The National Center for Advancing Translational Sciences (NIH) funded an earlier $275 thousand project grant award (September 15, 2023, completing August 31, 2024). Two awards (combined potential value $1.4 million) reach ultimate completion within the next twenty-four months and face recompete exposure. Combined dollars obligated across all awards ($3.8 million) exceed combined potential value, indicating strong funding commitment relative to stated ceilings. The vendor operates with no subcontractor footprint and places no work on government-wide vehicles or parent IDIQs.
Quick answers
What is Inaedis, Inc.'s UEI?
Inaedis, Inc.'s Unique Entity ID (UEI) in SAM.gov is ZN3PYM5VY1W9.
What is Inaedis, Inc.'s CAGE code?
Inaedis, Inc.'s CAGE code is 11VU0.
What is Inaedis, Inc.'s primary NAICS code?
Inaedis, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Inaedis, Inc. located?
Inaedis, Inc.'s physical address in SAM.gov is 114 Castleton Rd, Princeton, NJ 08540, USA.
Is Inaedis, Inc. registered in SAM.gov?
Yes. Inaedis, Inc.'s SAM.gov registration is active through February 15, 2027.
What is Inaedis, Inc.'s most recent federal award?
Inaedis, Inc.'s most recent federal contract award is Thermal stabilization and self-administered delivery of heat-sensitive medical countermeasures using room temperature… (W911SR26CA013), from ACC Aberdeen Proving Ground, on April 13, 2026.
On GovTribe
See Inaedis, Inc.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors